MalarVx, Inc. funding

MalarVx, Inc., a biotechnology company based in Seattle, WA, filed a Form D with the SEC on August 25, 2026 and reported $125K raised of a $2.5M offering.

Amount raised$125K

Offering size$2.5M

Filed with the SECAugust 25, 2026

First saleAugust 8, 2026

IndustryBiotechnology

SecuritiesOther

LocationSeattle, WA

FoundedMore than 5 years ago

Entity typeCorporation

Investors so far2

Minimum investment$25K

Revenue range$1,000,001 - $5,000,000

View the original Form D on SEC EDGAR ↗ · All rounds filed Aug 25

Other health care rounds in Washington

Key Proteo, Inc.$2.3M · Oct 23Biotechnology Hexamer Therapeutics, Inc$500K · Sep 15Biotechnology Ora Biomedical, Inc.$205K · Nov 13Biotechnology Seattle Neurosound Solutions, Inc.$100K · Sep 22Other Health Care Q-Immune, Inc.$25K · Sep 28Biotechnology